The Kidney Health Initiative (KHI) is a public-private partnership among the American Society of Nephrology (ASN), the U.S. Food and Drug Administration (FDA), and with more than 70 member companies and organizations committed to catalyzing innovation and the development of safe, effective, patient-centered therapies for people with kidney diseases.